Startups
Telormedix is a clinical stage biopharmaceutical company focused on targeted immunity in the treatment of cancer and other diseases.
Overview
Employees
1-10
Total raised
$14.51M
Founded date
2007
Investors 1
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
Funding Rounds 2
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Jan 10, 2012 | Funding round | $7.91M |
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Dec 8, 2014 | Orphan Drug Status Granted to Telormedix´ lead product | |
| May 19, 2014 | Telormedix’s Cancer Drug Successfully Completes Phase II Trials | |
| Dec 2, 2013 | Telormedix Raises CHF 6 M in Series B Financing Round | |
| Aug 7, 2013 | Telormedix Receives EU Funding | |
| Jan 7, 2013 | Telormedix: Go-ahead for Phase II trials | |
| Jun 4, 2012 | Telormedix, Foamix Receive EU Funding | |
| Mar 19, 2012 | Telormedixs TMX-101 Exhibits High Safety | |
| Mar 6, 2012 | Telormedix and SUPSI Receive Funding from CTI | |
| Feb 1, 2012 | Telormedix elected member of multi-million collaborative research programme |
Show more
Reviews 0
FAQ about Telormedix SA
When was Telormedix SA founded?
Telormedix SA was founded in 2007.
How much funding has Telormedix SA raised?
Telormedix SA has raised $14.51M in total across 2 funding rounds.
What funding rounds has Telormedix SA raised?
Parsers VC lists 2 funding rounds of Telormedix SA, among them a funding round of $7.91M on Jan 10, 2012.
What has the press written about Telormedix SA?
Parsers VC has collected 12 articles mentioning Telormedix SA, among them “Orphan Drug Status Granted to Telormedix´ lead product” (Dec 8, 2014) and “Telormedix’s Cancer Drug Successfully Completes Phase II Trials” (May 19, 2014).
Is Telormedix SA still active?
Yes, Telormedix SA is active; its latest activity on Parsers VC dates from Sep 25, 2015.